Health at a Glance: Asia/Pacific 2022

Measuring Progress Towards Universal Health Coverage

image of Health at a Glance: Asia/Pacific 2022

This seventh edition of Health at a Glance Asia/Pacific presents a set of key indicators of health status, the determinants of health, health-care resources and utilisation, health-care expenditure and financing, and quality of care across 27 Asia-Pacific countries and territories. It also provides a series of dashboards to compare performance across countries and territories, and a thematic analysis on the health impact of COVID-19. Drawing on a wide range of data sources, it builds on the format used in previous editions of Health at a Glance, and gives readers a better understanding of the factors that affect the health of populations and the performance of health systems in these countries and territories. Each of the indicators is presented in a user-friendly format, consisting of charts illustrating variations across countries and territories, and over time, brief descriptive analyses highlighting the major findings conveyed by the data, and a methodological box on the definition of the indicators and any limitations in data comparability. An annex provides additional information on the demographic and economic context in which health systems operate.


Screening, survival and mortality for breast cancer

The burden of breast cancer among women is significant in the Asia-Pacific region, where it is the cancer with the highest incidence and mortality rates in South-East Asia and the highest incidence and second highest mortality rates in Western Pacific region. In 2020, according to estimates based on pre‑pandemic trend, approximately 948 000 women were expected to be newly diagnosed with breast cancer and over 316 000 died of the disease in the region (International Agency for Research on Cancer (IARC), 2022[17]; see indicator “Mortality from cancer” in Chapter 3). Several factors are known to increase the risk of breast cancer, such as increasing age, genetic predisposition, oestrogen replacement therapy and lifestyle factors including obesity, physical inactivity, nutrition habits and alcohol consumption (World Cancer Research Fund/American Institute for Cancer Research, 2018[1]; González-Jiménez et al., 2014[2]).



This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error